Cargando…

Proteasome inhibitors attenuated cholesterol-induced cardiac hypertrophy in H9c2 cells

The Ubiquitin proteasome system (UPS) plays roles in protein degradation, cell cycle control, and growth and inflammatory cell signaling. Dysfunction of UPS in cardiac diseases has been seen in many studies. Cholesterol acts as an inducer of cardiac hypertrophy. In this study, the effect of proteaso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyunjung, Park, Jinyoung, Kim, Eunice EunKyeong, Yoo, Young Sook, Song, Eun Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2016
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070706/ https://www.ncbi.nlm.nih.gov/pubmed/26592933 http://dx.doi.org/10.5483/BMBRep.2016.49.5.187

Ejemplares similares

Assay Systems for Profiling Deubiquitinating Activity
por: Cho, Jinhong, et al.
Publicado: (2020)

Deubiquitinating Enzymes: A Critical Regulator of Mitosis
por: Park, Jinyoung, et al.
Publicado: (2019)

MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11
por: Park, Jinyoung, et al.
Publicado: (2022)

USP35 regulates mitotic progression by modulating the stability of Aurora B
por: Park, Jinyoung, et al.
Publicado: (2018)

MiR‐195 and miR‐497 suppress tumorigenesis in lung cancer by inhibiting SMURF2‐induced TGF‐β receptor I ubiquitination
por: Chae, Dong‐Kyu, et al.
Publicado: (2019)

The Multifaceted Roles of USP15 in Signal Transduction
por: Das, Tanuza, et al.
Publicado: (2021)

USP15 regulates dynamic protein–protein interactions of the spliceosome through deubiquitination of PRP31
por: Das, Tanuza, et al.
Publicado: (2017)

USP15 regulates dynamic protein–protein interactions of the spliceosome through deubiquitination of PRP31
por: Das, Tanuza, et al.
Publicado: (2017)

USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2
por: Cho, Jinhong, et al.
Publicado: (2020)

Structural and functional characterization of USP47 reveals a hot spot for inhibitor design
por: Shin, Sang Chul, et al.
Publicado: (2023)

Structural basis for recruiting and shuttling of the spliceosomal deubiquitinase USP4 by SART3
por: Park, Joon Kyu, et al.
Publicado: (2016)

Regulation of Deubiquitinating Enzymes by Post-Translational Modifications
por: Das, Tanuza, et al.
Publicado: (2020)

USP15 and USP4 facilitate lung cancer cell proliferation by regulating the alternative splicing of SRSF1
por: Das, Tanuza, et al.
Publicado: (2022)

Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
por: Park, Jinyoung, et al.
Publicado: (2020)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats
por: Lee, Eunjo, et al.
Publicado: (2016)

H727 cells are inherently resistant to the proteasome inhibitor carfilzomib, yet require proteasome activity for cell survival and growth
por: Lee, Min Jae, et al.
Publicado: (2019)

Curcumin Attenuation of Lipopolysaccharide Induced Cardiac Hypertrophy in Rodents
por: Chowdhury, Rupak, et al.
Publicado: (2013)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
por: Wang, Yan, et al.
Publicado: (2020)

AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
por: Cha, Byung-Hyun, et al.
Publicado: (2021)

Effective Delivery of Hypertrophic miRNA Inhibitor by Cholesterol‐Containing Nanocarriers for Preventing Pressure Overload Induced Cardiac Hypertrophy
por: Zhi, Ying, et al.
Publicado: (2019)

KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure
por: Lee, Jeong Hyun, et al.
Publicado: (2020)

Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy
por: Li, Qiaoling, et al.
Publicado: (2016)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study
por: Kim, In-Sub, et al.
Publicado: (2017)

Calcium inhibitor inhibits high glucose-induced hypertrophy of H9C2 cells
por: Xu, Xiaohong, et al.
Publicado: (2020)

Small molecule activator of Nm23/NDPK as an inhibitor of metastasis
por: Lee, Jae-Jin, et al.
Publicado: (2018)

A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice
por: Selsby, Joshua, et al.
Publicado: (2012)

Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018)

Engineered Circular RNA Sponges Act as miRNA Inhibitors to Attenuate Pressure Overload-Induced Cardiac Hypertrophy
por: Lavenniah, Annadoray, et al.
Publicado: (2020)

The complex of Fas-associated factor 1 with Hsp70 stabilizes the adherens junction integrity by suppressing RhoA activation
por: Song, Soonhwa, et al.
Publicado: (2022)

TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells
por: Cheng, Kai-Chun, et al.
Publicado: (2019)

Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)

Roselle attenuates cardiac hypertrophy after myocardial infarction in vivo and in vitro
por: Si, Lislivia-Yiang-Nee, et al.
Publicado: (2019)

Andrographolide contributes to the attenuation of cardiac hypertrophy by suppressing endoplasmic reticulum stress
por: Tian, Qingxin, et al.
Publicado: (2022)

Intuitive Modification of the Friedewald Formula for Calculation of LDL-Cholesterol
por: Hong, Jinyoung, et al.
Publicado: (2023)

The function of LncRNA-H19 in cardiac hypertrophy
por: Su, Wenhua, et al.
Publicado: (2021)

Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90
por: Shin, Sang Chul, et al.
Publicado: (2020)

The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα–SOD2 pathway
por: Xie, Yifan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pshadf20lntaskd39ebkm1nj3l